Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06ABJ
|
||||
Former ID |
DNC005856
|
||||
Drug Name |
[2-(4-Fluoro-1H-indol-3-yl)-ethyl]-dimethyl-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527668] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H15FN2
|
||||
Canonical SMILES |
CN(C)CCC1=CNC2=C1C(=CC=C2)F
|
||||
InChI |
1S/C12H15FN2/c1-15(2)7-6-9-8-14-11-5-3-4-10(13)12(9)11/h3-5,8,14H,6-7H2,1-2H3
|
||||
InChIKey |
ISJZKVWGUWBUFG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527668] | |
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527668] | ||
5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527668] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.